ST PharmLtd Dividends and Buybacks

Dividend criteria checks 0/6

ST PharmLtd is a dividend paying company with a current yield of 0.57%. Next payment date is on 24th April, 2025 with an ex-dividend date of 27th December, 2024.

Key information

0.6%

Dividend yield

n/a

Buyback Yield

Total Shareholder Yieldn/a
Future Dividend Yield0.6%
Dividend Growth-18.0%
Next dividend pay date24 Apr 25
Ex dividend date27 Dec 24
Dividend per share₩500.000
Payout ratio30%

Recent dividend and buyback updates

Recent updates

Should You Be Adding ST PharmLtd (KOSDAQ:237690) To Your Watchlist Today?

Nov 22
Should You Be Adding ST PharmLtd (KOSDAQ:237690) To Your Watchlist Today?

ST Pharm Co.,Ltd.'s (KOSDAQ:237690) Shares Climb 29% But Its Business Is Yet to Catch Up

Aug 30
ST Pharm Co.,Ltd.'s (KOSDAQ:237690) Shares Climb 29% But Its Business Is Yet to Catch Up

Is Now The Time To Put ST PharmLtd (KOSDAQ:237690) On Your Watchlist?

Aug 17
Is Now The Time To Put ST PharmLtd (KOSDAQ:237690) On Your Watchlist?

Is ST Pharm Co.,Ltd. (KOSDAQ:237690) Trading At A 41% Discount?

May 09
Is ST Pharm Co.,Ltd. (KOSDAQ:237690) Trading At A 41% Discount?

Why ST PharmLtd's (KOSDAQ:237690) Earnings Are Better Than They Seem

Mar 22
Why ST PharmLtd's (KOSDAQ:237690) Earnings Are Better Than They Seem

ST Pharm Co.,Ltd. (KOSDAQ:237690) Stock Rockets 54% As Investors Are Less Pessimistic Than Expected

Mar 18
ST Pharm Co.,Ltd. (KOSDAQ:237690) Stock Rockets 54% As Investors Are Less Pessimistic Than Expected

Investors Who Bought ST PharmLtd (KOSDAQ:237690) Shares A Year Ago Are Now Up 221%

Mar 16
Investors Who Bought ST PharmLtd (KOSDAQ:237690) Shares A Year Ago Are Now Up 221%

Calculating The Fair Value Of ST Pharm Co.,Ltd. (KOSDAQ:237690)

Jan 22
Calculating The Fair Value Of ST Pharm Co.,Ltd. (KOSDAQ:237690)

What Type Of Shareholders Own The Most Number of ST Pharm Co.,Ltd. (KOSDAQ:237690) Shares?

Dec 23
What Type Of Shareholders Own The Most Number of ST Pharm Co.,Ltd. (KOSDAQ:237690) Shares?

Health Check: How Prudently Does ST PharmLtd (KOSDAQ:237690) Use Debt?

Nov 26
Health Check: How Prudently Does ST PharmLtd (KOSDAQ:237690) Use Debt?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: A237690 is not paying a notable dividend for the KR market, therefore no need to check if payments are stable.

Growing Dividend: A237690 is not paying a notable dividend for the KR market, therefore no need to check if payments are increasing.


Dividend Yield vs Market

ST PharmLtd Dividend Yield vs Market
How does A237690 dividend yield compare to the market?
SegmentDividend Yield
Company (A237690)0.6%
Market Bottom 25% (KR)1.2%
Market Top 25% (KR)3.9%
Industry Average (Pharmaceuticals)1.1%
Analyst forecast (A237690) (up to 3 years)0.6%

Notable Dividend: A237690's dividend (0.57%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (1.24%).

High Dividend: A237690's dividend (0.57%) is low compared to the top 25% of dividend payers in the KR market (3.91%).


Earnings Payout to Shareholders

Earnings Coverage: A237690 is not paying a notable dividend for the KR market.


Cash Payout to Shareholders

Cash Flow Coverage: A237690 is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 09:14
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ST Pharm Co.,Ltd. is covered by 20 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Heeyoung LeeDaishin Securities Co. Ltd.
Yoonjin LimDaishin Securities Co. Ltd.
Jisoo LeeDAOL Investment & Securities Co., Ltd.